Neuropace, Inc. NPCE Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
- Neuropace, Inc. (NPCE) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number of $2.56M in Q1 2026.
- How has Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number changed year-over-year?
- Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number increased by 0.1% year-over-year, from $2.55M to $2.56M.
- What is the long-term trend for Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, number has grown at a -3.8% compound annual growth rate (CAGR), from $3.04M to $2.6M.